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1. INTRODUCTION
Paeoniae are herbaceous perenniel plants belonging to the flowering plant fam-
ily Paeoniceae. They are native to Asia, southern Europe and western North
America, where their roots are commonly used as medicine, especially in China,
Japan, Korea and Bulgaria. This is due to their biological activities as antiox-
idant, antitumor, antipathogenic, anticoagulant, anti-inflammatory, analgesic,
sedative, and against female diseases.
Over 260 compounds have been isolated from the plants of Paeoniceae which ac-
count for their biological activity. Besides flavonoids, tannins, stilbenes, steroids,
triterpenoids etc. also an abundance of monoterpenes with a very compact α-
pinene structure have been obtained (Fig. 1.1).
Fig. 1.1: α-Pinene structure
Paeoniflorin (P2) and its aglycone Paeoniflorigenin (P3) were isolated from
Paeonia albiflora PALLAS by Shibata and collaborators already in the 1960ies.
[1] Only recently, Paeonisuffrone (P1) and its mono- (12) and diacetate (13),
and Paeonisuffral (P4) were isolated from Paeonia suffruticosa ANDREWS and
their absolute stereostructures determined by Yoshikawa et al. (Fig. 1.2). [2, 3]
These compounds account for the biological activity of japanese Shakuyaku,
which is applied in oriental medicine as analgesic, anti inflammatory drug, an-
tispasmodic, astringent and sedative. [4, 5]
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Also, the diminishing effect on cognitive dysfunctions of cholinergic origin of
Shakuyaku-San, a herbal medicine prepared from the roots of Paeonia, has
been discovered. Therefore, it is applied in the treatment of Alzheimer’s dis-
ease. The high interest in its synthesis lies not only in its bioactivity, but also in
the difficulty that arises from the somewhat complicated access to its structure
of a highly oxidated, compact pinene skeleton.
R2O
O
O
R1O
P1: R1=R2=H
12: R1=Ac, R2=H
13: R1=R2=Ac
P2
GluO
BzO
O
O
Me
OH
P3
HO
BzO
O
O
Me
OH
H
H
O
HO
O
OH
P4
O
Fig. 1.2: Monoterpenes isolated from Paoeniae
2. ANTECEDENTS
2.1 Synthesis of (-)-Paeonisuffrone and (+)-Paeonisuffrone
(-)-Paeonisuffrone has been obtained in its optically active form starting from
the tricyclic ketone I (Fig.2.1) by Hatakeyama and collaborators. [6]
Racemic resolution was performed by means of transformation into the optically
active acetate III via the O-methyl mandelate ester II. Oxidative degradation
of the isopropyl group, applying the conditions described by Criegee [7, 8], re-
sulted in the hydroxyacetate IV and allowed subsequent transformation of V,
obtained by deprotection and anew protection as bencylidene acetal, into (-)-
Paeonisuffrone (P1).
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Fig. 2.1: a: (i) NaBH4, MeOH, -20
oC. (ii) (R)-O-methyl mandelic acid, DCC-
DMAP (cat.); b: (i) LAH, THF; (ii) Ac2O, pyr, DMAP (cat); c: O3,
MeOH, -78oC, p-NO2C6H4COCl, Et3N-DMAP (cat), CH2Cl2; d: (i)
NaOMe, MeOH; (ii) PhCHO, pTsOH.H2O (cat.), benzene, reflux; e: (i)
(COCl)2, DMSO, CH2Cl2, -60
oC, Et3N; (ii) H2, Pd(OH)2, MeOH-AcOEt-
H2O
(+)-Paeonisuffrone was synthesized in the university group of Prof. Francisco
Alberto Bermejo Gonza´lez starting from S-(+)-Carvone, using similar methods
as in this work (Fig.2.2). [9]
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Once obtained the epoxy pivalate 6’, a Ti(III) promoted radical cyclization
gives the bicyclic compound 7a’. After protection of the diol as benzylidene
acetal, an allylic oxidation reaction is carried out to give 9’, which can easily
be transformed into the tetracyclic compound 10’ by applying a slightly basic
milieu. Finally, deprotection of the diol via hydrogenation leads to the target
molecule (+)-Paeonisuffrone (11’).
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Fig. 2.2: a: Cp2TiCl2, Zn, THF, 24h, rt; b: BDMA, PPTS, CH2Cl2, 24h, rt; c:
CrO3, DMP, CH2Cl2, 4h, -20
◦C; d: NaOH 10M, CH3OH, 24h, rt; e: H2,
Pd/C, etyhl acetate, rt
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2.2 (-)-Paeoniflorigenin and (-)-Paeoniflorin
Regarding the synthesis of (-)-Paeoniflorigenin and (-)-Paeoniflorin, there ex-
ist notable precedent synthetic studies performed by Hatakeyama, Takano and
Corey. [10, 11, 12]
The strategies of Hatakeyama and Takano (Fig.2.3) with regard to the obtention
of the tricyclic derivative I are based on the [2+2] intramolecular photocycliza-
tion of the insaturated diene ester VII which is obtained in ten steps starting
from the 3-ethylen dioxy butanal VI with an overall yield of 47%. Transforma-
tion of racemic I, obtained with a yield of 64% in one step starting from VII, into
the enantiomeric pure cyclohexanone VIII was performed in three steps via the
O-methyl mandalate ester II with 35% yield. Subsequently, the hydroxycarbon-
ate aglycone IX was synthesized with a yield of 21%, carrying out a sequency
of six steps and, finally, the natural product P2 was obtained in two steps with
67% yield. This gives an overall yield for the synthesis of (-)-Paeoniflorin of
about 1.5%.
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Fig. 2.3: strategy followed by Hatakeyama et all
The strategy of Corey (Fig.2.4) is based on two key cyclization processes (cationic
and radical, respectively). The first cyclization step consists in the rearrange-
ment of the epoxy lactol XI, which can be obtained in four steps from the
triisopropylsilyl ether of dihydro m-Cresol (X) with an overall yield of 17%, pro-
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moted by the triisopropylsilyl triflate, and gives compound XII with 35% yield.
The second key step is the radical cyclization of the chloroacetone XIII in-
duced by Samarium(II) iodide. This gives access to the tricyclic sceleton of
(-)-Paeoniflorin (XIV) and occurs with 93% yield. Consequently, XV is ob-
tained with a yield of 47% through transformations of the functional groups in
seven steps. Finally, the application of a three-step reaction sequence leads to
the target molcule P2, obtained with an overall yield of 17%. The overall yield
for the synthesis of (-)-Paeoniflorin is therefore of about 0.5%.
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Fig. 2.4: strategy followed by Corey et al.
3. OBJECTIVES
The main objective of the presented work is the sythesis of the (-)-Paeonisuffrone
mono- and diacetate, respectively, starting from (S)-(-)-Carvone following the
retrosynthetic scheme as shown below (Fig. 3.1).
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Fig. 3.1: retrosynthetic analysis
During the synthesis, the following problems need attention:
1. Radical cyclization of the epoxy enone 6 promoted by Ti(III) and the
stereoselectivity of the reaction.
2. Protection of the diol 7a in acidic milieu, avoiding Grob fragmentation.
[13]
3. Allylic oxidation of the cyclohexane skeleton of the diol pivalate 8.
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4. Intramolecular Michael cyclization: The hydrolisis of compound 9 should
promote the intramolecular cyclization of the hydroxy function of the
hydroxy derivative 9a on the double bond of the bicyclic cyclohexanone.
5. Deprotection of the benzylidene actetal 10 in reductive milieu resulting in
the diol 11.
6. Regioselective protection of the primary alcohol only, or of both alcohol
functions to obtain the target molecules 12 and 13, respectively.
4. METHODS
Starting from the natural product R-(-)-Carvone, we planned to synthesize the
epoxy pivalate 6, which after cyclization formed the basis for the α-pinene struc-
ture of the target molecules, in five steps.
First, a radical allylic halogenation of the double bond was expected to give
the chloride 2. Nucleophilic substitution followed by the saponification of
the resulting acetate in basic milieu should result in the formation of (-)-10-
Hydroxycarvone 4. Subsequently, the primary double bond would be epoxidized
by treatment with tert-butyl hydroperoxide and, finally, by protecting the re-
maining free hydroxyl group with pivaloyl chloride we anticipated to get struc-
ture 6. [14, 15, 16]
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Fig. 4.1: Synthetic scheme leading to epoxy pivalate 6
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The key step of the synthesis of these natural monoterpenes is the radical cy-
clization of the epoxy pivalate 6, promoted by Ti(III) (Fig.4.2). Experience
gained by the university group of Prof. Francisco Alberto Bermejo Gonza´lez
during the last four years allowed us to admit the low diastereoselection of the
process (7a:7b ≈ 2:1) with 67% yield. [17].
Isolation of the diol 7a and its protection with the benzylidene acetal was ex-
pected to allow the formation of the bicyclic pivalate 8. Correspondingly, we
anticipated the formation of 8b parting from the diol 7b.
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Fig. 4.2: Synthetic scheme of Ti(III) promoted cyclization
Allylic oxidation of 8 followed by an intramolecular Michael cyclization of the
primary alcohol 9b on the enone functionality should allow us to isolate the
tricyclic derivative 10.
Subsequently, deprotection by hydrogenolysis with Pd/C catalysis should give
(-)-Paeonisuffrone as product (11) (Fig.4.3).
Furthermore, treatment of 11 with acetic anhydride (1.1 eq) and pyridine in
dichloromethane at 0◦C was expected to allow the isolation of 12 and 13 with
26% and 15% yields, respectively (Fig.4.4).
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Fig. 4.3: Synthetic scheme leading to (-)-Paeonysuffrone
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5. RESULTS AND DISCUSSION
5.1 Preparation of the starting material:
(R)-2-(4-methyl-5-oxocyclohex-3-en-1-yl)-2,3-epoxy-1-propanol
pivalate (mixture of epoxides)
The synthesis of the starting material for the obtention of functionalized α-
pinenes, the epoxy pivalate 6 was accomplished starting from (R)-(-)-Carvone
(Fig. 5.1). [14, 15, 16]
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Fig. 5.1: Scheme 1
First, the radical allylic halogenation of (R)-(-)-Carvone was performed by treat-
ment of 1 with an aqueous suspension of calcium hypochlorite for 2h. The pure
allylic chloride 2 was obtained after purification by flash column cromatography
with 90% yield.
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The spectroscopic properties (Figs. 9.1-9.4) were identical to those described
for (R)-5-(3-chloroprop-1-en-2-yl)-2-methylcyclohex-2-enone. [16]
Furthermore, the allylic acetate was obtained by displacement of the chloride
with potassium acetate in DMF at 55◦C for 24h. By fractionation of the crude
product by flash column cromatography we were able to isolate pure 3 with
83% yield.
The spectroscopic properties obtained for this compound were found identical
to those described previously for (R)-2-(4-methyl-5-oxocyclohex-3-en-1-yl)allyl
acetate (Figs. 9.5-9.8). [16]
Subsequently, the acetate was saponified by treatment of the acetate 3 under
basic conditions at room temperature for 2h. Fractionation of the crude product
by flash column chromatography led to the isolation of 4 with 83% yield.
The spectroscopic properties of the obtained alcohol (Figs. 9.9-9.12) were found
identical to those described for (R)-5-(3-hydroxyprop-1-en-2-yl)-2-methylcyclo-
hex-2-enone. [16]
Thereafter, epoxidation of the allylic double bond was achieved by treatment of
the alcohol 4 with tBuOOH in Toluene for 2h at 80◦C. Standard workup pro-
cedures and purification of the crude product by flash column chromatography
led to the isolation of 5 with 88% yield.
The spectroscopic properties obtained for 5 were found identical to those de-
scribed for (R)-2-(4-methyl-5-oxocyclohex-3-en-1-yl)-2,3-epoxypropan-1-ol (Figs. 9.13-
9.16)
Finally, the alcohol functionality was protected by reaction of the epoxy alcohol
5 with pivaloyl chloride and pyridine. The epoxy pivalate 6 was obtained with
98% yield by fractionation by flash chromatography.
The spectroscopic properties (Figs. 9.17-9.20) obtained for 6 were found iden-
tical to those described in literature for (R)-2-(4-methyl-5-oxocyclohex-3-en-1-
yl)-2,3-epoxy-1-hidroxy pivalate.
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The overall yield of these five steps is therefore 53%. Since these reactions were
all already very well studied and not known to give problems while working with
larger quantities, we were able to synthesize some reserve for further experiman-
tation.
5.2 Study of the radical cyclization reaction promoted by Ti(III)
The radical cyclization of the epoxy pivalates 6 was accomplished by treatment
of the starting material with Cp2TiCl, obtained by reduction of the titanocene
chloride Cp2TiCl2 with metallic Zn in THF. [18, 19, 20, 21, 22, 23, 24, 25, 26, 27]
The product turned out to be a diastereoisomeric mixture of the diols 7a and
7b, and the elimination product 7c in very small quantities (Fig. 5.2).
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HO
Fig. 5.2: Scheme 2
The diastereoselectivity was found to be rather low with a
7a : 7b = 2 : 1 ratio.
This was not only problematic because of the loss of substance since the di-
astereomer 7b did not give the wanted product in the next step, but also because
separation of the two diastereomers by flash column cromatography was some-
what problematic and time-consuming.
Another problem of this reaction is the fact that while working with increasing
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amounts the yield drops. Therefore we confined ourselves to work with amounts
of starting material 6 not exceeding 250 mg per attempt.
It is known in literature that the formation of Cp2TiCl is accompanied by the
formation of ZnCl2. The latter is considered to be a Lewis acid and can therefore
promote the aperture of the epoxide and its transformation into the correspon-
dent alcohol, known as Grob fragmentation reaction. [13]
The formation of 7c can be rationalized in terms of the elimination process of
the pivalate functionality and simultaneous formation of a double bond in the
titanoxy anion 6b. The anion is formed by the transference of a second electron
from the Ti(III) reagent to the titanoxy radical 6a (Fig. 5.3).
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Ti (III)
O
OPivTi(IV)O
.
O
OPivTi(IV)O
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6 6a 6b
Ti (III)
7c
O
HO
Fig. 5.3: Scheme 3
The structural assignment of both isomers 7a and 7b was achieved by careful
analysis of the spectroscopic data (Figs. 9.21- 9.36), mainly the HMBC and the
ROESY spectra.
The 1H/13C-correlations along two and three bonds (HMBC, Figs. 9.26, 9.34)
enabled us to identify the signals of the CH2 group next to the pivalate function
in the structures 7a and 7b. The signals in the ROESY spectra (Figs. 9.24, 9.24)
allowed the identification of the Nuclear Overhauser Effect between the exo pro-
ton of the bridge of the cyclobutane and the hydroxymethyl group next to it in
both diastereomers (Fig. 5.4).
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Fig. 5.4: NOE in structures 7a and 7b
5.3 Protection of the diol by formation of the bencylidene acetal
Once obtained the diol 7a, we proceeded to the protection of the two free hy-
droxyl groups by treatment with benzaldehyde dimethyl acetal (BDMA) under
acidic conditions (Fig. 5.5).
OO
PivO
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CH2Cl2
7a 8
H
Fig. 5.5: Scheme 4
By fractionation of the crude reaction product by flash chromatography we were
able to isolate 8 with 67% yield. [28]
The proposed structure for the acetal 8 was affirmed by the study of the spec-
troscopic properties, above all the HMBC (Fig. 9.42) and ROESY (Fig. 9.40)
spectra.
The correlations along three bonds enabled the identification of the signals of
the CH2 group next to the pivalate functionality. In the ROESY spectrum could
be observed the NOE between the exo proton of the bridge of the cyclobu-
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tane (δ = 3.24ppm), the hydroxymethyl group of the acetal (δ = 4.25ppm and
δ = 4.43ppm) and the bencylic proton (δ = 5.93ppm) of the molecule (Fig. 5.6).
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HH
H
HH
H
H
5.93 5.32 (s)
1.59 (d)3.24 (dd)
4.25(d)
4.43(d)
4.31(d)
4.34(d)
O
Fig. 5.6: NOE in stucture 8
5.4 Allylic oxidation of the cyclohexyl skeleton
The allylic oxidation of the acetal 8 was achieved using Cr(VI) oxide and DMP.
The reaction was carried out by stirring at -20◦C for 5h (Fig. 5.7). [29]
OO
PivO
Ph
CrO3, DMP
CH2Cl2
OO
PivO
Ph
O
OO
PivO
Ph
O
+
8 9a 9b
H OHH
Fig. 5.7: Scheme 5
The crude product was fractionated by flash chromatography and the tricyclic
enones 9a and 9b were obtained with 65% and 25% yields, respectively.
Study of the spectroscopic data confirmed the proposed structure for 9b and
the assumption that a second oxidation took place at the bencylic position due
to excess of CrO3.
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The spectroscopic properties of 9a (Figs. 9.46-9.54) and 9b (Figs. 9.55-9.61)
allowed the confirmation of the proposed structures by similar studies of the
spectra to those already described for the compounds 7a, 7b and 8.
The signals of the CH2 group next to the pivalate function were identified using
HMBC (Figs. 9.51, 9.60). Careful study of the ROESY spectra (Figs. 9.49, 9.58)
led to establishing the correlation between the exo proton of the cyclobutane
bridge and the hydroxymethyl group bonded to the bencyldene acetal (Fig. 5.8).
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4.67
4.84
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H
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Fig. 5.8: NOE in structures 9a and 9b
5.5 Obtention of the tetracyclic system via intramolecular Michael
addition
The formation of the oxymethylenic bridge via cyclization of the hydroxyl fun-
tion reacting with the enone funcitonality was achieved by treatment of 9a in
basic conditions (Fig. 5.9).
After purification by flash column chromatography, the tetracyclic compound
10 was isolated with 42% yield.
Structural assignment of 10 was achieved by means of its complete spectro-
scopic analysis (Figs. 9.62-9.69), basically consulting its HMBC (Fig. 9.67) and
ROESY (Fig. 9.65) spectra (Fig. 5.10).
Successful transformation could be asserted through the disappearance of the
1H-NMR signal of the pivalate group (δ = 1.17ppm) present in structure 9a
(Fig. 9.46).
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Fig. 5.9: Scheme 6
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Fig. 5.10: NOE in structure 10
5.6 Deprotection of the benzyliden acetal
Deprotection of the benzyliden acetal 10 was achieved by Palladium catalized
hydrogenolysis (Fig. 5.11).
Compound 10 was stirred with the catalyst under hydrogen atmosphere at room
temperature to give the free diol 11 with 90% yield.
The isolated compound (Fig. 5.12) resulted to be (-)-Paeonisuffrone by com-
parison of its spectroscopical properties (Figs. 9.70-9.77) with those described
by Yoshikawa et all. [2, 3]
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Fig. 5.11: Scheme 7
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Fig. 5.12: NOE in structure 11
5.7 Formation of (-)-Paeonisuffrone mono- and diacetate
To obtain the target molecule 12, specific protection of the primary alcohol
function only was carried out (Fig. 5.13).
O
O
OH
HO
11
O
O
OH
AcO
12
+
O
O
OAc
AcO
13
Ac2O
Pyridine
Fig. 5.13: Scheme 8
(-)-Paeonisuffrone was stirred with acetic anhydride and pyridine under argon
atmosphere for 20 hours. Due to excess of acetic anydride, part of the tertiary
alcohol function reacted also, and the diacetate 13 formed.
Fractionation of the crude product by flash column chromatography led to the
isolation of the mono- and diacetates 12 and 13 with 26% and 15% yield.
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Full study of the spectroscopic data of 12 (Figs. 9.78-9.83) and 13 (Figs. 9.84-
9.89) was performed and the structures proposed confirmed by the signals of
the acetate functions:
For compound 12 we find the characteristic 1H-NMR signal at δ = 2.11ppm
(s), the 13C signal of the carboxyl group at δ = 171.5ppm and an additional
peak at δ ≈ 20ppm which corresponds to the methyl group of the acetate.
For compound 13 the corresponding signals are found at δ = 2.08ppm (s)
and δ = 2.12ppm (s) in the 1H-NMR spectrum. In the 13C-NMR signals at
δ = 169.5ppm and δ = 170.5ppm and two additional peaks at δ ≈ 20ppm can
be seen, which correspond, as above, to the carboxyl groups and the methyl
groups of the acetates, respectively.
The synthesis of the target molecules, the (-)-Paeonisuffrone acetates 12 and
13, in 11 steps was successful with a somewhat low overall yield of less than 1%,
which is mostly due to the loss of substance in step 6 when two diastereomers
form and step 8, in which oxidation on two sites may occur producing the
byproduct 9b.
6. CONCLUSION
6.1 Summerization
1. Preparation of the epoxy pivalate 6 in 5 steps starting form the natural
product R-(-)-Carvone was successfully carried out with an overall yield
of 53% following the sythetic route shown in Fig. 6.1.
O O O
O O
1 2 3
4 5
Cl OAc
OH OH
O
O
6
OPiv
O
Ca(ClO)2, CO2 KOAc
CH2Cl2/H2O DMF
K2CO3
MeOH/H2O
VO(acac)2, tBuOOH
Toluene
PivCl, pyridine
CH2Cl2
Fig. 6.1: Synthetic route to epoxy pivalate 6
2. Intramolecular radical cyclization of the epoxy pivalate 6, promoted by
Ti(III), led to the formation of the diastereomeric diols 7a (49% yield) and
7b (27% yield) (Fig.6.2). Separation via flash column chromatography
on silica gel rendered possible the isolation and complete charactariza-
tion of both isomers. The proposed structures were confirmed by study
of the spectroscopic data of the compounds, especially of the HMBC
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(Figs. 9.26, 9.34) and ROESY spectra (Figs. 9.24, 9.32).
O
OPiv
O
Ti(III)
OH
PivO
HO
OH
HO
PivO
7b
7a
6
Fig. 6.2: Cyclization reaction giving 7a and 7b
3. Protection of the diol 7a using benzaldehyde dimethyl acetal (BDMA) and
pyridinium p-toluenesulfonate (PPTs) in CH2Cl2 was successful (Fig.6.3).
Isolation of the benzylidene acetal 8 by flash column chromatography al-
lowed its structural assignment based on its spectroscopic data (Figs. 9.37-
9.44).
OH
PivO
HO OO
PivO
Ph
BDMA
PPTs
7a 8
H
Fig. 6.3: Protection of diol
Unfortunately, the same conditions applied to the diol 7b lead to 7c, the
product of Grob fragmentation [13] of the starting material (Fig.6.4).
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OH
HO
PivO
7b
O
HO
7c
BDMA
PPTs
Fig. 6.4: Grob fragmentation
4. Allylic oxidation of the cyclohexenyl derivative 8 by treatment with the
oxidant complex CrO3
.DMP yielded the enone 9a with 16% yield. The
tertiary alcohol 9b was isolated as a byproduct (Fig.6.5).
OO
PivO
Ph
8
OO
PivO
Ph
O
H
OO
PivO
Ph
O
OH
9b
9a
H
Fig. 6.5: Allylic oxidation
5. Intramolecular cyclization of the pivalate on the enone functionality of
9a was performed under basic conditions by treatment with NaOH (5M)
in methanol, and subsequent acidification of the crude reaction product
(Fig.6.6). After purification by flash column chromatography on silica gel,
the pure product resulted to be the tricyclic compound 10 based on its
spectroscopic properties, which was obtained with 42% yield.
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Fig. 6.6: Intramolecular Michael cyclization
6. Deprotection of the benzylidene acetal 10 was successfully carried out by
Palladium catalyzed hydrogenolysis at room temperature (Fig.6.7). The
transformation to (-)-Paeonysuffrone was quantitative.
OO
O
OPh
O
O
OH
HOH2, Pd/C
10 11
H
Fig. 6.7: Deprotection via Palladium catalyzed hydrogenolysis
7. Treatment of a dichloromethane solution of 11 with acetic anhydride in
pyridine afforded a mixture of the (-)-Paeonysuffrone monoacetate 12 and
the diacetate 13 with 26% and 15% yields, respectively.
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Fig. 6.8: Acetylation of diol 11
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6.2 Future Prospects
The roots of chinese peonies still provide an abundance of investigation topics.
Not all of its components are known yet and a lot of the ones isolated have not
been obtained via synthesis.
The group of Prof. Francisco Alberto Bermejo Gonza´lez goes on working on this
subject and has developed strategies to synthesize a variety of components of
Paeoniceae (Paeoniflorin XVIIa(P2) and its aglycone XVIIb; Albiflorin XVI-
IIa and its aglycone XVIIIb; Paeoniflorigenone XIXa, 7R-Paeonimetabolin-I
XIXb and 7S-Paeonimetabolin-I XIXc; the three bicyclic lactones Paeonilac-
tone A XXa, Paeonilactone B XXb and Paeonilactone C XXc; Paeonisuffral
XXIa and its methyl ether XXIb; Paeonisuffrone XXII) starting from the cyclic
enone XVI (Fig. 6.9).
They are now actively working on a new strategy to synthesize the byciclic enone
XVI, different from the rout presented in this work, but still starting from the
natrual product R-(-)-Carvone, and on the synthesis of Albiflorin (XVIIIa) and
its aglycone XVIIIb.
Compound XXIII has already been obtained by way of an 11 step synthesis with
an overall yield of 5% and should be easily transformed into XVI (Fig. 6.10).
As shown in this work, compound XVI (equivalent to structure 7a) can be
transformed into the bencylidene acetal 10 in 3 steps. The resulting protected
(-)-Paeonisuffrone may then give way to the synthesis of Albiflorin (XVIIIa)
and Paeoniflorin (XVIIa), and their aglycones XVIIIb and XVIIb, respectively
(Fig. 6.11).
Finally, the synthesis of the Albiflorin aglycone XVIIIa would give access to the
Paeonilactones A (XXa), B (XXb), and C (XXc) by way of its rearrangement
in acidic milieu (Fig 6.12).
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Fig. 6.10: Alternative synthetic route to XVI
6. Conclusion 33
O
O
O
Me O
H Ph
10
OO
O
Me O
H Ph
O
OO
O
Me
RO
H Ph
O
H
R2O
OR1
O
Me
RO
O
H
XX
VI
II
XX
IX
XV
III
a:
 R
1=
Bz
; R
2=
G
lu
b:
 R
1=
H
; R
2=
H
O
O
O
Me
HO R
Ph
H
O
O
O
O
Me R
PhH
R2O
OR1
O
O
Me OH
XX
X
XX
XI
XX
VI
I
a:
 R
1=
Bz
; R
2=
G
lu
 (P
2)
b:
 R
1=
H
; R
2=
H
a:
 R
=C
   
   
CH
b:
 R
=C
   
  C
H 2
a:
 R
=C
O
CH
3
b:
 R
=O
Ac
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7. EXPERIMENTAL SECTION
7.1 General techniques
7.1.1 Optical rotation
The optical rotation values were measured using a Perkin Elmer 241 digital
polarimeter with a cell of 1 dm length.
7.1.2 NMR spectra
Most of the spectra were obtained using a Varian Mercury spectrometer (200 MHz),
although a few were measured on a Bruker Mod. WP-200-SY spectrometer
(200 MHz) and a Bruker Avance spectrometer (400 MHz), respectively.
Chemical shifts δ are expressed in ppm with reference to the magnetic field of
the spectrometer, and coupling constants in Hz.
7.1.3 Mass spectrometry
A quadrupole mass spectrometer Shimadzu QP5000 applying EI ionization tech-
nique was used for obtaining gas phase mass spectrometry data. A DB-5 col-
umn of 30 m length, 0.25 mm diameter, and 0.25 µm thickness of the stationary
phase was used.
HRMS spectra were obtained using a hybrid spectrometer of cuadrupole-TOF
Applied Biosystems QSTAR XL operating with ESI ionization technique. The
samples were introduced into the spectrometer via infusion of a solution in
methanol and were ionized at 5 KV. The indicated precision, measuring masses
inferior to 400 Da, was 5 ppm.
7.1.4 IR spectroscopy
All IR spectra wer obtained using a Nicolet IR100 spectrometer with a resolution
of 4 cm−1.
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7.2 Reagents and solvents
The solvents THF, toluene and hexane were depurated by distillation of the
commercial product over metallic sodium in argon atmosphere for immediate
use.
Dichloromethane and ethyl acetate were distilled over calcium hydride in argon
atmosphere for immediate use.
Other liquid reagents and solvents were distilled immediately before use.
7.3 Chromatographic techniques
7.3.1 Flash column chromatography
Silica gel Merck 60 (0.040-0.063 mm) was used for all flash column chro-
matographies, and pressure was applied using pumps. Eluents consisted of
mixtures of hexane and ethyl acetate in different ratios, as indicated in every
case. The composition of the obtained fractions was checked by TLC.
7.3.2 Thin layer chromatography
Plates of the type F 1500/ LS254 were used for TLC. The Visualization was
achieved using an UV lamp with wavelengths of 254 and 300 nm, or by colour-
ing with a solution of anisaldehyde in H2SO4/ethanol (25:75) and subsequent
heating to about 120◦C.
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7.4 (R)-5-(3-chloroprop-1-en-2-yl)-2-methylcyclohex-2-enone
O
Cl
Fig. 7.1: 2
To a solution of Ca(ClO)2 (17.13 g, 119.82 mmol, 1.2 eq) in water (26 mL)
was added a solution of R-(-)-Carvone (15.00 g, 99.85 mmol, 1.0 eq) in CH2Cl2
(262.5 mL). While stirring, dry ice was added little by little during two hours of
reaction.
The formed salts were filtered. The aqueous layer of the resulting filtrate was
separated and extracted with CH2Cl2 (3 x 50 mL). The combined organic layers
were washed with brine (3 x 50 mL), dried over Na2SO4 anhydrous, and the
solvent evaporated under reduced pressure.
The residue was chromatographed over silica gel, eluting with hexane/ethyl
acetate (8:2) to give the chloro substituted product 2 (yellow oil, 16.47 g,
89.68 mmol, 90%).
[α20D ] = -43.3
o (c = 1.14 mg/mL, CHCl3)
1H-NMR: (CDCl3) (Fig. 9.1) δ[ppm] = 1.79 (s, 3H), 2.1-2.7 (m, 5H), 4.09 (s,
2H), 5.06 (s, 1H), 5.26 (s, 1H), 6.77 (s, 1H)
13C-NMR: (CDCl3) (Fig. 9.2) δ[ppm] = 15.34 (q), 31.25 (t), 37.85 (d), 42.90
(t), 46.67 (t), 114.88 (t), 135.42 (s), 143.65 (d), 146.54 (s), 198.37 (s)
IR: (Fig. 9.3) ν[cm−1] = 3453, 2957, 2924, 1726, 1672, 1463, 1433, 1370,
1254, 1109, 1057, 905
MS-EI: (Fig. 9.4) m/z (%): 184 (4) (M+), 149 (15), 107 (13), 93 (29), 82
(100), 69 (6)
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7.5 (R)-2-(4-methyl-5-oxocyclohex-3-en-1-yl)allyl acetate
O
OAc
Fig. 7.2: 3
To a solution of 2 (4.00 g, 21.33 mmol, 1.0 eq) in DMF (50 mL) was added
potassium acetate (4.46 g, 45.49 mmol, 2.1 eq). The reaction mixture was
stirred at 55◦C under argon atmosphere for six hours.
After cooling to room temperature, water (50 mL) was added and the aqueous
layer extracted with diethyl ether (7 x 30 mL). The combined organic layers
were washed with water (3 x 30 mL) and brine (2 x 50 mL), dried over Na2SO4
anhydrous, and the solvent evaporated under reduced pressure.
The residue was purificated via flash column chromatography over silica gel,
eluting with hexane/ethyl acetate (7:3) to give the acetate 3 (clear oil, 3.72 g,
17.87 mmol, 83%).
[α20D ] = 59.58
o (c = 1.685 mg/mL, CHCl3)
1H-NMR: (CDCl3) (Fig. 9.5) δ[ppm] = 1.75 (s, 3H), 2.05 (s, 3H), 2.28-2.57
(m, 5H), 4.55 (s, 2H), 5.01 (s, 1H), 5.14 (s, 1H), 6.71 (s, 1H)
13C-NMR: (CDCl3) (Fig. 9.6) δ[ppm] = 15.35 (q), 20.60 (q), 31.18 (t), 38.37
(d), 42.50 (t), 65.41 (t), 113.32 (t), 135.36 (s), 143.78 (d), 145.19 (s), 170.21
(s), 198.62 (s)
IR (film): (Fig. 9.7) ν[cm−1] = 2953, 2924, 2890, 1742, 1674, 1433, 1371,
1231, 1111, 1045, 1030, 905
MS-EI: (Fig. 9.8) m/z (%): 208 (5) (M+), 182 (18), 148 (100), 106 (56), 82
(97)
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7.6 (R)-5-(3-hydroxyprop-1-en-2-yl)-2-methylcyclohex-2-enone
O
OH
Fig. 7.3: 4
To a solution of 3 (3.70 g, 17.70 mmol, 1.0 eq) in methanol/water (1:1) (50 mL)
was added a saturated solution of potassium carbonate in water (11 mL). The
mixture was stirred rigorously during two hours of reaction.
Afterwards, the methanol was evaporated under reduced pressure and the re-
maining aqueous solution saturated with NaCl and extracted with CH2Cl2 (3 x 20 mL).
The combined organic layers were washed with brine (3 x 20 mL), dried over
Na2SO4 anhydrous, and the solvent was evaporated under reduced pressure.
The residue was cleaned chromatographically over silica gel, eluting with hex-
ane/ethyl acetate (1:1) to give the alcohol 4 (clear oil, 2.45 g, 14.76 mmol,
83%).
[α20D ] = -90.82
o (c = 1.22 mg/mL, CHCl3)
1H-NMR: (CDCl3) (Fig. 9.9) δ[ppm] = 1.78 (s, 3H), 2.2-3.0 (m, 5H), 4.15 (s,
2H), 4.95 (s, 1H), 5.15 (s, 1H), 6.73 (s, 1H)
13C-NMR: (CDCl3) (Fig. 9.10) δ[ppm] = 15.28 (q), 31.45 (t), 38.06 (d), 43.05
(t), 64.32 (t), 110.01 (t), 135.21 (s), 144.64 (d), 150.18 (s), 199.54 (s)
IR: (Fig. 9.11) ν[cm−1] = 3424, 2924, 2888, 1667, 1433, 1370, 1248, 1111,
1044, 905
MS-EI: (Fig. 9.12) m/z (%): 166 (26) (M+), 148 (30), 133 (8), 106 (69), 82
(100), 65 (11)
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7.7 (R)-5-((S)-2-(hydroxymethyl)oxiran-2-yl)-2-methylcyclohex-2-
enone
O
OH
O
Fig. 7.4: 5
To a solution of 4 (2.35 g, 14.14 mmol, 1.0 eq) and Vanadyl acetylacetonate
(37 mg, 0.14 mmol, 0.01 eq) in toluene (25 mL) was added tert-butyl hydroper-
oxide (1.9 mL, 16.97 mmol, 1.2 eq) at 80◦C under argon atmosphere and the
reaction was stirred for two hours.
After cooling to room temperature, a solution of Na2S2O3 10% (4.5 mL) was
added and the mixture stirred for 15 minutes. The aqueous layer was extracted
with diethyl ether (3 x 20 mL). The combined organic layers were washed with
brine (3 x 20 mL), dried over Na2SO4 anhydrous, and the solvent was evapo-
rated under reduced pressure.
The residue was chromatographed on silica gel, eluting with hexane/ethyl ac-
etate (1:3) to give the epoxy alcohol 5 (slightly yellow oil, 1.60 g, 12.44 mmol,
88%).
[α20D ] = -49.22
o (c = 1.46 mg/mL, CHCl3)
1H-NMR: (CDCl3) (Fig. 9.13) δ[ppm] = 1.73 (s, 3H), 2.0-3.0 (m, 7H), 3.5-4.0
(m, 3H), 6.70 (s, 1H)
13C-NMR: (CDCl3) (Fig. 9.14) δ[ppm] = 15.408 (q), 28.014 (t)*, 36.780 (d)*,
39.269 (t)*, 48.519 (t)*, 60.567 (s), 62.243 (t)*, 135.493 (s), 143.775 (d)*,
198.354 (s)*
IR: (Fig. 9.15) ν[cm−1] = 3472, 2926, 2891, 1738, 1713, 1672, 1433, 1370,
1165, 1109, 1049
MS-EI: (Fig. 9.16) m/z (%): 182 (2) (M+), 164 (3.5), 151 (10), 108 (100), 82
(64), 67 (17)
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7.8 ((R)-2-((R)-4-methyl-5-oxocyclohex-3-en-1-yl)oxiran-2-yl)-
methyl pivalate
O
OPiv
O
Fig. 7.5: 6
To a solution of 5 (1.55 g, 8.51 mmol, 1.0 eq) in CH2Cl2 (15 mL) were
added pyridine (0.82 mL, 10.21 mmol, 1.2 eq) and pivaloyl chloride (1.18 mL,
9.57 mmol, 1.125 eq) at 0◦C. The reaction mixture was stirred at room tem-
perature under argon atmosphere for 24 hours.
Afterwards, the solution was diluted with CH2Cl2 and washed with HCl 0.5M
(2 x 15 mL), a saturated solution of NaHCO3 (2 x 15 mL), and brine (2 x 15 mL).
The organic layer was dried over Na2SO4 anhydrous and evaporated under re-
duced pressure.
The residue was cleaned chromatographically over silica gel, eluting with hex-
ane/ethyl acetate (1:1) to give the epoxy pivalate 6 (clear oil, 2.22 g, 8.35 mmol,
98%).
[α20D ] = 17.63 (c = 1.685 mg/mL, CHCl3)
1H-NMR: (CDCl3) (Fig. 9.17) δ[ppm] = 1.22 (s, 9H), 1.78 (s, 3H), 2.0-2.5 (m,
7H), 3.5-3.7 (m, 2H), 6.65 (s, 1H)
13C-RMN: (CDCl3) (Fig. 9.18) δ[ppm] = 15.43 (q), 26.14 (t), 27.00 x 3 (q),
37.71 (t), 38.74 (d), 46.36 (t), 58.25 (s), 64.32 (t), 73.76 (s), 135.18 (s),
144.23 (d), 178.32 (s), 198.86 (s)
IR: (Fig. 9.19) ν[cm−1] = 3460, 2974, 1733, 1674, 1482, 1281, 1154, 1037,
906, 757
HRMS-EI: (Fig. 9.20) M+Na calculated for C15H22O4Na: 289.1410, experimen-
tal: 289.1419
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7.9 (1-hydroxy-6-(hydroxymethyl)-2-methylbicyclo[3.1.1]hept-2-en-6-
yl)methyl pivalate
OH
PivO
HO
Fig. 7.6: 7a
Dry THF (15 mL) was desoxydated by passing through argon during one hour.
Solution A: Titanocene Cp2TiCl2 (854 mg, 3.43 mmol, 3.65 eq) and zinc (448 mg,
6.85 mmol, 7.3 eq) were dissolved in desoxydated, dry THF (6 mL) and the so-
lution was stirred for one hour under argon (change of color of the solution from
red to green).
Solution B: The epoxy pivalate 6 (250 mg, 0.94 mmol, 1.00 eq) was dissolved
in dry, desoxydated THF (9 mL) under argon.
Solution B was added to solution A via cannula, and the reaction mixture stirred
for 20 hours under argon atmosphere (change of color of the solution from green
to red).
Afterwards, a saturated solution of KH2PO4 (30 mL) was added and the mix-
ture stirred for five hours. The formed salts were filtered and washed with ethyl
acetate. The aqueous layer of the resulting filtrate was separated and extracted
with ethyl acetate (3 x 50 mL). The combined organic layers were washed with
brine (3 x 30 mL), dried over Na2SO4 anhydrous, and the solvent evaporated
under reduced pressure.
The residue was chromatographed on silica gel, eluting with hexane/ethyl ac-
etate (8:2) to give the diastereoisomers 7a (yellow oil, 124.1 mg, 0.46 mmol,
49%) and 7b (yellow oil, 67.1 mg, 0.25 mmol, 27%). This corresponds to a
global yield of 75%.
7. Experimental Section 43
7a:
[α20D ] = -14.4 (c = 0.25 mg/mL, CHCl3)
1H-NMR: (CDCl3) (Fig. 9.21) δ[ppm] = 1.21 (s, 9H), 1.60 (s, 1H), 1.71 (d,
J=8.7 Hz, 1H), 1.78 (s, 3H), 2.2-2.3 (m, 2H), 2.44 (t, 1H), 2.69 (s, 1H), 3.37
(s, 1H), 3.88 (d, J=11.7 Hz, 1H), 4.15 (d, J=11.5 Hz, 1H), 4.17 (d, J=11.7
Hz, 1H), 4.46 (d, J=11.5 Hz, 1H), 5.30 (s, 1H)
13C-NMR: (CDCl3) (Fig. 9.22) δ[ppm] = 16.78 (q), 27.20 x 3 (q), 29.89 (d),
30.48 (t), 38.91 (s), 39.87 (t), 48.85 (s), 62.87 (t), 64.23 (t), 77.77 (s), 117.60
(d), 145.70 (s), 179.39 (s)
IR: (Fig. 9.27) ν[cm−1] = 3418, 2964, 2363, 1726, 1711, 1296, 1172
HMQC: (Fig. 9.25), HMBC (Fig. 9.26), COSY (Fig. 9.23), ROESY (Fig. 9.24)
HRMS-EI: (Fig. 9.28) M+Na calculated for C15H24O4Na: 291.1567, experimen-
tal: 291.1553
7b:
[α20D ] = +26.18
o (c = 0.615 mg/mL, CHCl3)
1H-NMR: (CDCl3) (Fig. 9.29) δ[ppm] = 1.1-1.3 (m, 9H), 1.7 (d, 1H), 1.80
(s, 3H), 1.9-2.5 (m, 5H), 2.41 (dd, 1H), 3.52 (d, J=11.28 Hz, 1H), 3.72 (d,
J=11.28 Hz, 1H), 4.56 (d, J=11.88 Hz, 1H), 4.67 (d, J=11.88 Hz, 1H), 5.31
(s, 1H)
13C-NMR: (CDCl3) (Fig. 9.30) δ[ppm] = 16.87 (q), 27.21 x 3 (q), 29.91 (d),
30.57 (t), 39.02 (t), 39.90 (s), 50.52 (s), 60.23 (t), 64.41 (t), 77.80 (s), 117.59
(d), 145.27 (s), 179.51 (s)
IR: (Fig. 9.35) ν[cm−1] = 3432, 2959, 1716, 1462, 1288, 1165, 1026
HMQC: (Fig. 9.33), HMBC (Fig. 9.34), COSY (Fig. 9.31), ROESY (Fig. 9.32)
HRMS-EI: (Fig. 9.36) M+Na calculated for C15H24O4Na: 268.1747, experimen-
tal: 268.1740
7. Experimental Section 44
7.10 ((2R,4aR,8aS)-8-methyl-2-phenyl-4,4a,5,6-tetrahydro-5,8a-
methanobenzo[d][1,3]dioxin-4a-yl)methyl pivalate
OO
PivO
Ph
H
Fig. 7.7: 8
To a solution of 7a (100.0 mg, 0.37 mmol, 1.0 eq) in dichloromethane (10 mL)
were added PPTs (tip of a spatula) and BDMA (0.062 mL, 0.41 mmol, 1.1 eq),
and the reaction mixture was stirred for 20 hours under argon atmosphere at
room temperature.
Afterwards, a saturated solution of NaHCO3 (10 mL) was added and stirred for
10 minutes, and the aqueous layer was extracted with ethyl acetate (3 x 15 mL).
The combined organic layers were washed with brine (3 x 10 mL), dried over
Na2SO4 anhydrous and the solvent evaporated under reduced pressure.
The residue was cleaned chromatographically on silica gel, eluting with hex-
ane/ethyl acetate (95:5) to give the protected compound 8 (clear oil, 88.4 mg,
0.25 mmol, 67%).
[α20D ] = +74.71
◦ (c = 0.60 mg/mL, CHCl3)
1H-NMR: (Fig. 9.37) δ[ppm] = 1.18 (s, J=0.24 Hz, 9H), 1.59 (d, J=4.56 Hz,
1H), 1.81 (s, 3H), 2.13-2.34 (m, 3H), 3.24 (dd, J=3.44 Hz J=4.5 Hz, 1H),
4.25 (d, J=0.88, 1H), 4.31 (d, J=0.96 Hz), 4.34(d, J=0.9 Hz, 1H), 4.43 (d,
J=6.0 Hz, 2H), 5.33 (s, 1H), 5.93 (s, 1H), 7.26-7.51 (m, 5H)
13C-NMR: (Fig. 9.38) δ[ppm] = 16.38 (q), 27.16 x 3 (q), 30.12 (t), 30.53
(t), 32.42 (d), 38.88 (s), 41.07 (s), 62.81 (t), 70.19 (s), 77.80 (s), 96.11 (d),
117.49 (d), 126.25 x 2 (d), 128.15 (d), 128.81 x 2 (d), 138.49 (s), 144.13 (s),
178.57 (s)
IR: (Fig. 9.43) ν[cm−1] = 2968, 1728.24, 1478.98, 1452.89, 1392.97, 1227.73,
1072.09, 749.84
7. Experimental Section 45
7.11 ((2R,4aR,8aS)-8-methyl-6-oxo-2-phenyl-4,4a,5,6-tetrahydro-
5,8a-methanobenzo[d][1,3]dioxin-4a-yl)methyl pivalate
OO
PivO
Ph
O
H
Fig. 7.8: 9a
A solution of DMP (431 mg, 4.49 mmol, 20 eq) and CrO3 (449.0 mg, 4.49 mmol,
20 eq) in CH2Cl2 (8 mL) was stirred at -20
◦C under argon atmosphere for 10
minutes. Afterwards, 8 (80.0 mg, 0.22 mmol, 1 eq) in CH2Cl2 (4 mL) was
added via cannula, and the reaction mixture stirred at -20◦C under argon at-
mosphere overnight.
Subsequently, a solution of NaOH 5M (2 mL) was added and the mixture stirred
during one hour at 0◦C. The organic layer was washed with a solution of HCl
0.1M (2 x 10 mL), with water until neutralized, and with brine (2 x 20 mL),
dried over Na2SO4 anhydrous, and the solvent evaporated under reduced pres-
sure.
The residue was cleaned chromatographically on silica gel, eluting with hex-
ane/ethyl acetate (8:2) to give the oxidized products 9a (13.0 mg, 0.035 mmol,
16%) and 9b (in small amounts as byproduct).
7. Experimental Section 46
9a:
[α20D ] = +84.4
◦ (c = 0.97 mg/mL, CHCl3)
1H-NMR: (Fig. 9.46) δ[ppm] = 1.17 (s, 9H), 2.21 (s, 3H) 2.28-2.51 (m, 1H),
2.82 (dd, J1=0.94 Hz , J2=3.26 Hz, 1H), 3.68 (dd, J1=3.34 Hz, J2=4.86 Hz,
1H), 4.23 (d, 1H), 4.43 (d, 1H), 4.46 (s, 2H), 5.79 (s, 1H), 6.02 (s, 1H), 7.38-
7.49 (m, 5H)
13C-NMR: (Fig. 9.47) δ[ppm] = 17.53 (q), 27.07 x 3 (q), 38.86 (s), 42.45 (t),
46.39 (d), 54.61 (s), 62.99 (t), 69.84 (t), 76,72 (d), 96.73 (d), 121.07 (d),
126.17 x 2 (d), 128.30 (d), 129.25 x 2 (d), 137.53 (s), 169.13 (s), 178.22 (s),
198.57 (s)
IR: (Fig. 9.52) ν[cm−1] = 2960.45, 2923.16, 2852.77, 1728.24, 1688, 1457.08,
1227.23
HMQC (Fig. 9.50), HMBC (Fig. 9.51), COSY (Fig. 9.48), ROESY (Fig. 9.49).
HRMS-EI: (Fig. 9.54) M+Na calculated for C22H26O5Na: 393.1656, experimen-
tal: 389.1998.
UV: (Fig. 9.53) λmax = 205 nm ( = 12024); λmax = 254 nm ( = 4780)
9b:
[α20D ] = +31.22
◦ (c = 0.6 mg/mL, CHCl3)
1H-NMR: (Fig. 9.55) δ[ppm] = 1.18 (s, 9H), 2.14 (d, J=0.74 Hz, 3H), 2.60
(d, J=4.34 Hz, 1H), 2.93 (c, J=3.34 Hz, 2H), 4.13 (d, J=5.94 Hz, 1H), 4.43
(d, J=5.94 Hz, 1H), 4.67 (d, J=6.1 Hz, 1H), 4.84 (d, J=6.1 Hz, 1H), 5.81 (t,
J=0.92 Hz, 1H), 7.44-8.04 (m, 5H)
13C-NMR: (Fig. 9.56) δ[ppm] = 18.31 (q), 27.09 x 3 (q), 38.90 (s), 45.06 (s),
46.55 (d), 48.15 (t), 62.78 (t), 62.94 (t), 77.62 (s), 121.01 (d), 127.80 x 2
(d), 128.53 (d), 129.33 (s), 129.69 x 2 (d), 133.47 (d), 166.80 (s), 171.09 (s),
199.53 (s)
HMQC (Fig. 9.59), HMBC (Fig. 9.60), COSY (Fig. 9.57), ROESY (Fig. 9.58).
HRMS-EI: (Fig. 9.61) M+Na calculated for C22H26O6Na: 409.16216, experi-
mental 409.1329
7. Experimental Section 47
7.12 (2R,4aS,5R,8S,8aR)-8-methyl-2-phenyldihydro-4H-8,4a-
(epoxymethano)-5,8a-methanobenzo[d][1,3]dioxin-6(5H)-one
OO
Ph
O
O
H
Fig. 7.9: 10
To a solution of 9a (40 mg, 0.11 mmol, 1.0 eq) in methanol (1 mL) was added
NaOH 5M (0.11 mL, 0.55 mmol, 5.0 eq) and the reaction stirred for 24 hours.
This time elapsed, the solvent methanol was evaporated under reduced pres-
sure, the residue dissolved in water and extracted with CH2Cl2 (5 x 8 mL). The
combined organic layers were washed with brine (3 x 10 mL), dried over Na2SO4
anhydrous, and the solvent evaporated under reduced pressure.
The crude product was fractionized via flash column chromatography on silica
gel, eluting with hexane/ethyl acetate (8:2) to thus give the tetracyclic com-
pound 10 (white crystals, 13.3 mg, 0.05 mmol, 42%).
[α20D ] = -0.88
o (c = 1.13 mg/mL, CHCl3)
1H-NMR: (Fig. 9.62) δ[ppm] = 1.25 (s, 3H), 2.16 (d, J=5.72 Hz, 1H), 2.59 (d,
J=8.98 Hz, 1H), 2.83 (dd, J1=3.5 Hz, J2=4.58 Hz, 1H), 3.15 (dd , J1=3.44Hz,
J2=5.72 Hz, 1H), 3.87 (d, J=5 Hz, 1H), 4.15 (s, 1H), 4.17 (d, J=1.44 Hz, 2H),
4.32 (d, J=6.06 Hz, 1H), 5.88 (s, 1H), 7.38-7.54 (m, 5H)
13C-NMR: (Fig. 9.63) δ[ppm] = 18.06 (q), 25.21 (q), 49.05 (d), 49.15 (t),
51.84 (s), 68.18 (t), 70.70 (t), 79.81 (s), 86.67 (s), 96.81 (s), 126.41 x 2 (d),
128.34 (d), 129.31 x 2 (d), 137.40 (s), 208.34 (s)
IR:(Fig. 9.68) ν[cm−1] = 2960.08, 2923.80, 2854.66, 1728.67, 1143.80, 1014.07
HMQC (Fig. 9.66), HMBC (Fig. 9.67), COSY (Fig. 9.57), ROESY (Fig. 9.65)
HRMS-EI: (Fig. 9.69) M+Na calculated for C17H18O4Na: 309.1108, experimen-
tal 309.1205
7. Experimental Section 48
7.13 (-)-Paeonysuffrone
O
O
OH
HO
Fig. 7.10: 11
A suspension of Pd/C (20 mg) in ethyl acetate (1 mL) was stirred for 15 min-
utes under hydrogen atmosphere. This time elapsed, a solution of 10 (45 mg,
0.16 mmol, 1.0 eq) in ethyl acetate (2 mL) was added via cannula and the
reaction mixture stirred for four hours under hydrogen atmosphere.
Subsequently, the residue was filtered over a column of celite, eluting with ethyl
acetate, and the solvent evaporated under reduced pressure to give the depro-
tected diol 11 (white crystals, 28.6 mg, 0.14 mmol, 90%).
[α20D ] = -17.34
o (c = 0.80 mg/mL, CHCl3)
1H-NMR: (Fig. 9.70) δ[ppm] = 1.31 (s, 3H), 2.20 (d, J=5.32 Hz, 2H), 2.29
(d, J=0.38 Hz, 1H), 2.33 (d, J=0.36 Hz, 2H), 2.46 (dd, J1=3.54 Hz, J2=4.82
Hz, 1H), 2.86 (d, J=3.5 Hz, 1H) 2.91 (d, J=8.8 Hz, 1H), 3.57 (d, J=5.06 Hz,
1H), 3.86 (ddd, J1=5.8 Hz, J2=10.42 Hz, J3=15.46 Hz, 1H) 4.88 (s, 1H)
13C-NMR: (Fig. 9.71) δ[ppm] = 19.23 (q), 33.10 (t), 49.97 (t), 50.13 (t), 62.71
(t), 63.03 (s), 71.75 (t), 82.16 (s), 87.59 (s), 212.93 (s)
IR: (Fig. 9.76) ν[cm−1] = 3372, 1727, 1458, 1240, 1166, 1052
HMQC (Fig. 9.74), HMBC (Fig. 9.75), COSY (Fig. 9.72), ROESY (Fig. 9.73)
HRMS-EI: (Fig. 9.77) M+Na calculated for C10H14O4Na: 221.0787, experimen-
tal 213.1127
7. Experimental Section 49
7.14 (-)-Paeonysuffrone mono- and diacetate
O
O
OR2
R1O
12: R1=Ac; R2=H
13: R1=R2=Ac
Fig. 7.11: (-)-Paeonysuffrone acetates
To a solution of 11 (27.6 mg, 0.14 mmol, 1.0 eq) in CH2Cl2 (1 mL) were added
pyridine (17 µL, 0.17 mmol, 1.5 eq) and acet anyhdride (16 µL, 0.17 mmol,
1.2 eq). The reaction mixture was stirred under argon atmosphere for 20 hours.
NaHCO3 sat. (2 mL) and chunks of ice were added. The mixture was stirred
for 30 minutes, and the aqueous layer extracted with CH2Cl2 (3 x 10 mL).
The combined organic layers were washed with a saturated solution of NaHCO3
(1 x 10 mL), HCl 1M (2 x 10 mL), and brine (2 x 10 mL), dried over Na2SO4
anhydrous and and the solvent evaporated under reduced pressure.
By means of flash column chromatography on silica gel, eluting with hex-
ane/ethyl acetate (1:2) the monoacetate 12 (white crystals, 8.7 mg, 0.04 mmol,
26%) and the diacetate 13 (white crystals, 6.0 mg, 0.02 mmol, 15%) were iso-
lated.
7. Experimental Section 50
12:
1H-NMR: (Fig. 9.78) δ[ppm] = 1.40 (s, 3H), 2.11 (s, 3H), 2.20 (d, 1H), 2.46
(m, 1H), 2.52 (dd, 1H), 2.83 (m, 2H), 3.68 (d, 1H), 3.89 (d, 1H), 4.36 (d, 1H),
4.41 (d, 1H)
. 13C-NMR: (Fig. 9.79) δ[ppm] = 18.92 (q), 20.87 (q), 31.24 (t), 48.36 (t),
48.47 (d), 59.82 (s), 62.71 (t), 69.53 (t), 81.25 (s), 85.70 (s), 171.59 (s),
208.98 (s)
HMQC (Fig. 9.82), HMBC (Fig. 9.83), COSY (Fig. 9.80), ROESY (Fig. 9.81)
13:
1H-NMR: (Fig. 9.84) δ[ppm] = 1.36 (s, 3H), 2.08 (s, 3H), 2.11 (s, 3H), 2.51
(d, 1H), 2.75 (m, 2H), 2.92 (d, 1H), 2.99 (m, 1H), 3.71 (d, 1H), 3.92 (d, 1H),
4.35 (d, 1H), 4.41 (d, 1H)
13C-NMR: (Fig. 9.85) δ[ppm] = 19.73 (q), 20.74 (q), 20.96 (q), 31.78 (t),
48.75 (t), 50.87 (d), 58.90 (s), 63.00 (t), 70.37 (t), 85.50 (s), 85.93 (s), 69.57
(s), 70.85 (s), 208.17 (s)
HMQC (Fig. 9.88), HMBC (Fig. 9.89), COSY (Fig. 9.86), ROESY (Fig. 9.87)
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9.1 Spectra of compound 2
Fig. 9.1: 1H-NMR spectrum of 2
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Fig. 9.3: IR spectrum of 2
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Fig. 9.4: mass spectrum of 2
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9.2 Spectra of compound 3
Fig. 9.5: 1H-NMR spectrum of 3
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Fig. 9.6: 13C-NMR spectrum of 3
9. Spectroscopic Data 60
Fig. 9.7: IR spectrum of 3
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9.3 Spectra of compound 4
Fig. 9.9: 1H-NMR spectrum of 4
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Fig. 9.10: 13C-NMR spectrum of 4
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Fig. 9.11: IR spectrum of 4
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9.4 Spectra of compound 5
Fig. 9.13: 1H-NMR spectrum of 5
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Fig. 9.14: 13C-NMR spectrum of 5
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Fig. 9.15: IR spectrum of 5
9. Spectroscopic Data 69
Fig. 9.16: mass spectrum of 5
9. Spectroscopic Data 70
9.5 Spectra of compound 6
Fig. 9.17: 1H-NMR spectrum of 6
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9.6 Spectra of compound 7a
Fig. 9.21: 1H-NMR spectrum of 7a
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Fig. 9.23: COSY-NMR spectrum of 7a
9. Spectroscopic Data 77
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Fig. 9.25: HMQC-NMR spectrum of 7a
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Fig. 9.26: HMBC-NMR spectrum of 7a
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Fig. 9.27: IR spectrum of 7a
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Fig. 9.28: mass spectrum of 7a
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9.7 Spectra of compound 7b
Fig. 9.29: 1H-NMR spectrum of 7b
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Fig. 9.30: 13C-NMR spectrum of 7b
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Fig. 9.31: COSY-NMR spectrum of 7b
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Fig. 9.32: ROESY-NMR spectrum of 7b
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Fig. 9.33: HMQC-NMR spectrum of 7b
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Fig. 9.34: HMBC-NMR spectrum of 7b
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Fig. 9.35: IR spectrum of 7b
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Fig. 9.36: mass spectrum of 7b
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9.8 Spectra of compound 8
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Fig. 9.44: mass spectrum of 8 using the TOF technique
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9.9 Spectra of compound 9a
Fig. 9.46: 1H-NMR spectrum of 9a
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9.10 Spectra of compound 9b
Fig. 9.55: 1H-NMR spectrum of 9b
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Fig. 9.57: COSY-NMR spectrum of 9b
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Fig. 9.59: HMQC-NMR spectrum of 9b
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9.11 Spectra of compound 10
Fig. 9.62: 1H-NMR spectrum of 10
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Fig. 9.63: 13C-NMR spectrum of 10
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Fig. 9.64: COSY-NMR spectrum of 10
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Fig. 9.67: HMBC-NMR spectrum of 10
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Fig. 9.68: IR spectrum of 10
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Fig. 9.69: mass spectrum of 10
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9.12 Spectra of compound 11
Fig. 9.70: 1H-NMR spectrum of 11
9. Spectroscopic Data 124
Fig. 9.71: 13C-NMR spectrum of 11
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Fig. 9.72: COSY-NMR spectrum of 11
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Fig. 9.73: ROESY-NMR spectrum of 11
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Fig. 9.74: HMQC-NMR spectrum of 11
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Fig. 9.75: HMBC-NMR spectrum of 11
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Fig. 9.76: IR spectrum of 11
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Fig. 9.77: mass spectrum of 11
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9.13 Spectra of compound 12
Fig. 9.78: 1H-NMR spectrum of 12
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Fig. 9.79: 13C-NMR spectrum of 12
9. Spectroscopic Data 133
Fig. 9.80: COSY-NMR spectrum of 12
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Fig. 9.81: ROESY-NMR spectrum of 12
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Fig. 9.82: HMQC-NMR spectrum of 12
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Fig. 9.83: HMBC-NMR spectrum of 12
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9.14 Spectra of compound 13
Fig. 9.84: 1H-NMR spectrum of 13
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Fig. 9.85: 13C-NMR spectrum of 13
9. Spectroscopic Data 139
Fig. 9.86: COSY-NMR spectrum of 13
9. Spectroscopic Data 140
Fig. 9.87: ROESY-NMR spectrum of 13
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Fig. 9.88: HMQC-NMR spectrum of 13
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Fig. 9.89: HMBC-NMR spectrum of 13
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10. APPENDIX
Abbreviations
AcOEt: ethyl acetate
AcOK: potassium acetate
BDMA: benzaldehyde dimethyl acetal
13C-NMR: Carbon Nuclear Magnetic Resonance Spectroscopy
Da: Dalton
DMAP: 4-Dimethylaminopyridine
DMF: dimethyl formamide
DMP: dimethyl pyrazole
EI: electron (impact) ionization
ESI: Electron Spray Ionization
Fig.: figure
1H-NMR: Proton Nuclear Magnetic Resonance Spectroscopy
Hex: hexane
HMBC: Heteronuclear Multiple Bond Correlation experiment
HMQC: Heteronuclear Multiple Quantum Coherence
HRMS: High Resolution Mass Spectrometry
Hz: Hertz
NOE: Nuclear Overhauser effect
PivCl: pivaloyl chloride
ppm: parts per million
PPTS: pyridinium p-toluenesulfonate
Pyr.: pyridine
ROESY: rotating frame NOE
tBuOOH: tert-Butyl hydroperoxide
THF: Tetrahydrofurane
TLC: thin layer chromatography
TOF: time of flight mass analyzer
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Abstract
In der vorliegenden Arbeit wird die Totalsynthese von (-)-Paeonisuffron Mono-
und Diacetat ausgehend von R-(-)-Carvon beschrieben. Dies sind zwei Be-
standteile der Wurzeln der chinesischen Pfingstrosen (Pa¨onien), welche in der
traditionellen Medizin von Japan, China, Korea und Bulgarien Anwendung finden.
Die Synthese verla¨uft u¨ber elf Stufen, wobei die Titan-katalysierte Zyklisierung
den Schlu¨sselschritt darstellt. Diese wird ausgelo¨st durch die O¨ffnung des zu-
vor synthetisierten Epoxids durch Elektronentransfer. Dabei entsteht die ho-
choxidierte α-Pinen-Grundstruktur, welche in den Zielmoleku¨len und anderen
komplexen, biologisch aktiven Terpenoiden vorhanden ist. Somit ero¨ffnet diese
Reaktion neue, effektive Wege zu deren Synthese.
In the presented work, the total synthesis of (-)-Paeonisuffrone mono- and di-
acetate starting from R-(-)-Carvone is described. These are two components of
the roots of chinese peonies which are used in the traditional medicins of Japan,
China, Korea and Bulgaria.
The synthesis consists of eleven steps, the Titanium catalyzed cyclization being
the key step. This is initiated by the opening of the before synthesized epoxide
by electron transfer. In this reaction, the highly oxidized α-pinene structure is
formed, which is present in the target molecules and other complex, biologically
active terpenoids. Thus, this reaction provides a new and effective approach to
their synthesis.
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